Soylu A, Kavukçu S, Türkmen M A, Kasap B, Soylu A, Bora S, Gülay H
Department of Pediatrics, Dokuz Eylul University Medical Faculty, Inciralti, Izmir, Turkey.
Transplant Proc. 2006 Jun;38(5):1286-9. doi: 10.1016/j.transproceed.2006.02.073.
Hyperlipidemia is a frequent complication after renal transplantation. Cyclosporine therapy is an important cause of hyperlipidemia. It is still controversial whether C0 or C2 is the most effective way to monitor blood cyclosporine concentrations to guide dosages. We sought to evaluate the relationship of C0 or C2 to serum lipid levels in the early and late posttransplant periods among adolescent renal transplant recipients. The posttransplantation charts of 26 adolescent renal transplant recipients were evaluated retrospectively. Serum C0 and C2 levels and serum lipid (triglyceride and total cholesterol) levels were analyzed both in the early (first 6 months) and the late (thereafter) posttransplant periods. Hypertriglyceridemia and hypercholesterolemia were defined as levels above the 95th percentile adjusted for age and gender. To evaluate the influence of C0 and C2 levels on serum lipids, we excluded one patient with familial hyperlipidemia. In addition, serum lipid levels of the remaining 25 patients were excluded in acute rejection periods and when the serum creatinine levels were above 2.5 mg/dL, representing chronic allograft nephropathy. Concurrently recorded serum C0 and C2 levels were present for only 21 patients. Overall, we evaluated the records of 245 visits for these 21 patients. The incidence of hyperlipidemia decreased in the late posttransplant period, being significant for hypercholesterolemia. C2 had strong negative correlation with serum lipids; it was significant for total cholesterol in the early posttransplant period (r=-0.542, P=.005), but weaker in the late posttransplant and whole posttransplant periods. Thus correlation of C2 with serum lipids showed differences during posttransplant follow-up. C0, on the other hand, was positively correlated with total cholesterol levels in all periods, being significant for the whole posttransplant period (r=0.293, P=.000) and for the late posttransplant period (r=0.196, P=.025). Although not statistically significant, C0 levels were higher among hypertriglyceridemic or hypercholesterolemic episodes both in the early and the late posttransplant periods. When only the C0 levels of all 25 patients were analyzed (789 visits), C0 and serum cholesterol levels were positively correlated both in the early and the late posttransplant periods (P=.013, r=0.198 and P=.000, r=0.177, respectively). We concluded that C0 has a more predictable correlation with serum cholesterol levels after renal transplantation in adolescent patients.
高脂血症是肾移植术后常见的并发症。环孢素治疗是高脂血症的一个重要原因。监测血中环孢素浓度以指导用药的最有效方法是C0还是C2,目前仍存在争议。我们试图评估青少年肾移植受者移植后早期和晚期C0或C2与血脂水平的关系。对26例青少年肾移植受者的移植后病历进行回顾性评估。分析移植后早期(前6个月)和晚期(此后)的血清C0和C2水平以及血脂(甘油三酯和总胆固醇)水平。高甘油三酯血症和高胆固醇血症定义为经年龄和性别校正后高于第95百分位数的水平。为评估C0和C2水平对血脂的影响,我们排除了1例家族性高脂血症患者。此外,在急性排斥期以及血清肌酐水平高于2.5mg/dL(代表慢性移植肾肾病)时,排除其余25例患者的血脂水平。仅21例患者同时记录了血清C0和C2水平。总体而言,我们评估了这21例患者245次就诊的记录。移植后期高脂血症的发生率下降,高胆固醇血症尤为明显。C2与血脂呈强负相关;在移植后早期与总胆固醇的相关性显著(r=-0.542,P=0.005),但在移植后晚期和整个移植期较弱。因此,C2与血脂的相关性在移植后随访期间存在差异。另一方面,C0在所有时期均与总胆固醇水平呈正相关,在整个移植期(r=0.293,P=0.000)和移植后晚期(r=0.196,P=0.025)均具有显著性。尽管无统计学意义,但在移植后早期和晚期的高甘油三酯血症或高胆固醇血症发作期间,C0水平均较高。当仅分析所有25例患者的C0水平(789次就诊)时,C0与血清胆固醇水平在移植后早期和晚期均呈正相关(分别为P=0.013,r=0.198和P=0.000,r=0.177)。我们得出结论,在青少年患者肾移植后,C0与血清胆固醇水平的相关性更具可预测性。